Explore the MiniMedTM 630G

  

Product Details

Wherever you want to go, the MiniMed™ 630G with SmartGuard™ technology can help you get there. This insulin pump and sensor system steps in when you need it; with convenient options and features, it makes it easy to enjoy a day that revolves around you.

INTEGRATED WITH CGM

With optional continuous glucose monitoring (CGM), the MiniMed™ 630G continuously checks your glucose levels helping to detect highs and lows. It works with SmartGuard technology to help you stay in range.

EXCLUSIVE CONTOUR® NEXT LINK 2.4 wireless blood glucose monitoring system

When combined with the CONTOUR® NEXT LINK 2.4 meter,1 results are wirelessly transmitted to help ensure accurate CGM calibration, insulin dosing, and remote bolusing in an easy-to-use sleek design.

 

630G

key features

 

SMARTGUARD TECHNOLOGY

Only  MiniMed™ systems have SmartGuard™ suspend on low technology, which takes action for you if your sensor glucose values go below a preset level*. If you don't respond to alarms, SmartGuard technology can pause insulin delivery for up to two hours — giving you time to recover.

BOLUS WIZARD CALCULATOR

This feature automatically calculates and recommends precise bolus doses and helps you avoid insulin stacking if you accidentally set boluses too close together.

PREDICTIVE ALERTS

The pump lets you know up to 30 minutes ahead of time if you’re trending high or low, so you can act sooner to keep your glucose levels where you want them.

BUILT-IN CGM

The sensor wirelessly sends glucose information to your pump every five minutes, so you can see how you’re doing, spot trends, and make adjustments.

630G

technology that helps you Stay in range*

   

MINIMED™ 630G PUMP

User-friendly, waterproof§ design

  • Waterproof protection
  • Colour screen with auto-brightness
  • Easy-to-use menu and buttons
  • Airplane mode for travel
  • Polished black exterior finish; easily customisable with a wide variety of personalised skins

Remote insulin dosing

  • Highly accurate wireless CONTOUR® NEXT LINK 2.4 meter (a MiniMed™ system exclusive)
  • Quick, easy delivery of a bolus

Fewer injections

  • Small device worn on your body that continuously delivers insulin
  • Tubing changes needed only every two or three days

Adjustable settings

  • Multiple insulin delivery settings

 EnLITE™  Glucose Sensor

Comfort

  • Up to six days of wear, easy insertion
  • Small sensor that moves with your body

Continuous glucose

  • Glucose readings every five minutes, right on your pump

Complete picture

  • Tracks your levels throughout the day, showing the effects of food, exercise and other activities
  • Up-to-date information that makes it easier to spot trends and make adjustments*.

Helpful alerts

  • Timely notifications when you’re going high or low
  • Adjustable volume for greater convenience

REQUEST MORE INFORMATION


By submitting this form you are consenting to and confirm the following:
  • That Medtronic can communicate with you regarding our diabetes products by telephone, fax, mail and/or e-mail.
  • That Medtronic stores information, including personal health information, on systems located outside of Canada.
  • That you have read and are aware of our privacy policy.
  • That you grant Medtronic of Canada permission to send you updates on diabetes and diabetes technology.
  • You may revoke this permission at any time by emailing medtronicdiabetescc@medtronic.com
  • Medtronic respects the confidentiality of personal information. We assure you we will not share your personal information, except as otherwise noted in our privacy policy.

TAKE THE NEXT STEP

Fill out the form to be contacted by a MiniMed 630G system consultant from Medtronic.

MiniMed 630G

MINIMEDTM 630G support

Find product support for the MiniMedTM 630G.

Visit MiniMedTM 630G support
Father and Child viewing device

READ REAL PATIENT STORIES

Find real stories from people who are using CGM or pump technology for diabetes.

DISCOVER STORIES
*

CGM uses a special sensor to measure sugar levels just below the skin known as interstitial fluid. These sensor glucose (SG) values are different from blood glucose (BG) measurements using a BG meter. Sensor glucose values should not be used to make treatment decisions. Patients should always do a BG fingerstick before they make treatment decisions.

Refers to suspend on low. WARNING: Do not use the Suspend on low feature to prevent or treat low glucose. Always confirm your sensor glucose reading using your BG meter and follow the instructions of your healthcare professional to treat low glucose. Using Suspend on low alone to prevent or treat low glucose may result in prolonged hypoglycaemia.

The Bolus Wizard™ calculator does not account for manual injections and could prompt you to deliver more insulin than needed. Too much insulin may cause hypoglycaemia. Consult with your healthcare professional for how long you need to wait after a manual injection before you can rely on the active insulin calculation of your Bolus Wizard™ calculator.

§

At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours.

||

Individual results may vary.

1

Bailey T, et al. Accuracy, Precision, and User Performance Evaluation of the CONTOUR® NEXT LINK 2.4 Blood Glucose Monitoring System. Poster presented at the 7th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD); 2014 February 5–8, Vienna, Austria.

2

Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia. 2012;55:3155–3162.

3

Doyle EA, Weinzimer SA, Steffen AT, Ahern JAH, Vincent M, Tamborlane WV. A randomized prospective trial comparing the efficacy of insulin pump therapy with multiple daily injections using insulin glargine. Diabetes Care. 2004;27(7):1554–1558.

4

Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care. 1996;19:324–327.

5

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.